Literature DB >> 23952145

Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.

Christopher J Bean1, Sheree L Boulet, Genyan Yang, Amanda B Payne, Nafisa Ghaji, Meredith E Pyle, W Craig Hooper, Pallav Bhatnagar, Jeffrey Keefer, Emily A Barron-Casella, James F Casella, Michael R Debaun.   

Abstract

Genetic diversity at the human β-globin locus has been implicated as a modifier of sickle cell anaemia (SCA) severity. However, haplotypes defined by restriction fragment length polymorphism sites across the β-globin locus have not been consistently associated with clinical phenotypes. To define the genetic structure at the β-globin locus more thoroughly, we performed high-density single nucleotide polymorphism (SNP) mapping in 820 children who were homozygous for the sickle cell mutation (HbSS). Genotyping results revealed very high linkage disequilibrium across a large region spanning the locus control region and the HBB (β-globin gene) cluster. We identified three predominant haplotypes accounting for 96% of the β(S) -carrying chromosomes in this population that could be distinguished using a minimal set of common SNPs. Consistent with previous studies, fetal haemoglobin level was significantly associated with β(S) -haplotypes. After controlling for covariates, an association was detected between haplotype and rate of hospitalization for acute chest syndrome (ACS) (incidence rate ratio 0·51, 95% confidence interval 0·29-0·89) but not incidence rate of vaso-occlusive pain or presence of silent cerebral infarct (SCI). Our results suggest that these SNP-defined β(S) -haplotypes may be associated with ACS, but not pain or SCI in a study population of children with SCA.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute chest syndrome; genetic analysis; haplotype; sickle cell anaemia; β-globin

Mesh:

Substances:

Year:  2013        PMID: 23952145      PMCID: PMC4026174          DOI: 10.1111/bjh.12507

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  45 in total

Review 1.  Predicting clinical severity in sickle cell anaemia.

Authors:  M H Steinberg
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

2.  Molecular cloning and characterization of the human beta-like globin gene cluster.

Authors:  E F Fritsch; R M Lawn; T Maniatis
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

Review 3.  Clinical diversity of sickle cell anemia: genetic and cellular modulation of disease severity.

Authors:  M H Steinberg; R P Hebbel
Journal:  Am J Hematol       Date:  1983-06       Impact factor: 10.047

4.  Molecular characteristics of pediatric patients with sickle cell anemia and stroke.

Authors:  S A Sarnaik; S K Ballas
Journal:  Am J Hematol       Date:  2001-07       Impact factor: 10.047

5.  Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity.

Authors:  Ping An; Emily A Barron-Casella; Robert C Strunk; Robert G Hamilton; James F Casella; Michael R DeBaun
Journal:  J Allergy Clin Immunol       Date:  2011-03-09       Impact factor: 10.793

6.  Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity.

Authors:  D R Powars; H J Meiselman; T C Fisher; A Hiti; C Johnson
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-02

7.  Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

Authors:  Christopher J Bean; Sheree L Boulet; Dorothy Ellingsen; Meredith E Pyle; Emily A Barron-Casella; James F Casella; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Genyan Yang; Kimberly Jones; Solomon F Ofori-Acquah; W Craig Hooper; Michael R DeBaun
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

8.  Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.

Authors:  Bruce A Vendt; Robert C McKinstry; William S Ball; Michael A Kraut; Fred W Prior; Bruce Barton; James F Casella; Michael R DeBaun
Journal:  J Digit Imaging       Date:  2008-04-09       Impact factor: 4.056

9.  Haplotypes of beta S chromosomes among patients with sickle cell anemia from Georgia.

Authors:  Y Hattori; F Kutlar; A Kutlar; V C McKie; T H Huisman
Journal:  Hemoglobin       Date:  1986       Impact factor: 0.849

10.  Classical sickle beta-globin haplotypes exhibit a high degree of long-range haplotype similarity in African and Afro-Caribbean populations.

Authors:  Neil Hanchard; Abier Elzein; Clare Trafford; Kirk Rockett; Margaret Pinder; Muminatou Jallow; Rosalind Harding; Dominic Kwiatkowski; Colin McKenzie
Journal:  BMC Genet       Date:  2007-08-10       Impact factor: 2.797

View more
  8 in total

Review 1.  The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.

Authors:  Michael R DeBaun; Robert C Strunk
Journal:  Lancet       Date:  2016-06-18       Impact factor: 79.321

Review 2.  Beta-globin gene haplotypes among cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa?

Authors:  Valentina J Ngo Bitoungui; Gift D Pule; Neil Hanchard; Jeanne Ngogang; Ambroise Wonkam
Journal:  OMICS       Date:  2015-03

3.  A cortactin CTTN coding SNP contributes to lung vascular permeability and inflammatory disease severity in African descent subjects.

Authors:  Patrick Belvitch; Nancy Casanova; Xiaoguang Sun; Sara M Camp; Saad Sammani; Mary E Brown; Joseph Mascarhenas; Heather Lynn; Djanybek Adyshev; Jessica Siegler; Ankit Desai; Laleh Seyed-Saadat; Alicia Rizzo; Christian Bime; Gajendra S Shekhawat; Vinayak P Dravid; John P Reilly; Tiffanie K Jones; Rui Feng; Eleftheria Letsiou; Nuala J Meyer; Nathan Ellis; Joe G N Garcia; Steven M Dudek
Journal:  Transl Res       Date:  2022-02-15       Impact factor: 10.171

4.  Biomarker signatures of sickle cell disease severity.

Authors:  Mengtian Du; Sarah Van Ness; Victor Gordeuk; Sayed M Nouraie; Sergei Nekhai; Mark Gladwin; Martin H Steinberg; Paola Sebastiani
Journal:  Blood Cells Mol Dis       Date:  2018-05-16       Impact factor: 3.039

Review 5.  An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.

Authors:  Khuthala Mnika; Gift D Pule; Collet Dandara; Ambroise Wonkam
Journal:  OMICS       Date:  2016-09-16

6.  H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice.

Authors:  Gregory M Vercellotti; Fatima B Khan; Julia Nguyen; Chunsheng Chen; Carol M Bruzzone; Heather Bechtel; Graham Brown; Karl A Nath; Clifford J Steer; Robert P Hebbel; John D Belcher
Journal:  Front Pharmacol       Date:  2014-04-17       Impact factor: 5.810

7.  Meeting the emerging public health needs of persons with blood disorders.

Authors:  Christopher S Parker; James Tsai; Azfar-e-Alam Siddiqi; Hani K Atrash; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2014-09-19       Impact factor: 5.043

8.  Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.

Authors:  Ambroise Wonkam; Valentina J Ngo Bitoungui; Anna A Vorster; Raj Ramesar; Richard S Cooper; Bamidele Tayo; Guillaume Lettre; Jeanne Ngogang
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.